TIPIN Antibody (OTI2E6) [Janelia Fluor® 585]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-74528JF585
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Immunohistochemistry, Immunohistochemistry-Paraffin, Western Blot
Label
Janelia Fluor 585
Antibody Source
Monoclonal Mouse IgG1 Clone # OTI2E6
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Full length human recombinant protein of human TIPIN (NP_060328) produced in E.coli.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for TIPIN Antibody (OTI2E6) [Janelia Fluor® 585]
Application
Recommended Usage
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: TIPIN
Alternate Names
FLJ20516, TIMELESS interacting protein, TIMELESS-interacting protein
Gene Symbol
TIPIN
Additional TIPIN Products
Product Documents for TIPIN Antibody (OTI2E6) [Janelia Fluor® 585]
Product Specific Notices for TIPIN Antibody (OTI2E6) [Janelia Fluor® 585]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...